Cme (CME) Cash from Financing Activities (2010 - 2026)

Cme (CME) has reported Cash from Financing Activities for 17 consecutive years, with -$8.1 billion the latest figure, recorded in Q2 2026.

• Quarterly Cash from Financing Activities fell 138.53% year-over-year to -$8.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.3 billion (down 80.36% YoY) and the FY2025 annual result came in at $56.5 billion, up 1013.16% from the prior year.
• Cash from Financing Activities fell to -$8.1 billion in Q2 2026 per CME's latest filing, from $2.1 billion in the prior quarter.
• Over the last five years, Cash from Financing Activities for CME reached as high as $21.0 billion in Q2 2025 and fell as low as -$29.7 billion in Q2 2022.
• A 5-year average of -$1.0 billion and a median of $1.5 billion in 2022 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities sank 2380.44% — and 2025, when it soared 1105.91%.
• Year by year, Cash from Financing Activities stood at -$5.1 billion in 2022, then soared by 150.84% to $2.6 billion in 2023, then plunged by 138.02% to -$984.1 million in 2024, then surged by 1105.91% to $9.9 billion in 2025, then slumped by 181.74% to -$8.1 billion in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$8.1 billion, $2.1 billion, and $9.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.